These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9323503)

  • 1. Possible immunological problems of bioartificial liver support.
    te Velde AA; Flendrig LM; Ladiges NC; Chamuleau RA
    Int J Artif Organs; 1997 Aug; 20(8):418-21. PubMed ID: 9323503
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure.
    te Velde AA; Flendrig LM; Ladiges NC; Chamuleau RA
    Int J Artif Organs; 1997 Apr; 20(4):229-33. PubMed ID: 9195241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of potential immunological problems in the application of xenogenic hybrid liver support.
    Bornemann R; Smith MD; Gerlach JC
    Int J Artif Organs; 1996 Nov; 19(11):655-63. PubMed ID: 8970833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are cells in liver tissue relevant to immunology?
    Garvey JS
    Immunochemistry; 1975 Jul; 12(6-7):637-40. PubMed ID: 1102443
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of naturally occurring xenoantibodies in hyperacute rejection strengthened by their avid binding to ex vivo pig to human liver xenografts and to isolated pig liver preparations.
    Nair J; Fair JH; Burdick JF; Stephenson GR; Klein AS; Olson JL; Maley WR; Kittur DS
    Transplant Proc; 1994 Jun; 26(3):1344-5. PubMed ID: 8029934
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperglobulinaemia in liver disease.
    Thomas HC; MacSween RN; White RG
    Lancet; 1973 Jul; 2(7820):104-5. PubMed ID: 4123607
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of NK, NKT cells and macrophages in liver transplantation.
    Fahrner R; Dondorf F; Ardelt M; Settmacher U; Rauchfuss F
    World J Gastroenterol; 2016 Jul; 22(27):6135-44. PubMed ID: 27468206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and perspectives of bioartificial liver support.
    Naruse K; Makuuchi M
    Hepatogastroenterology; 2002; 49(43):91-5. PubMed ID: 11941991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological basis of certain immunological phenomena in liver diseases].
    Bezprozvannyi BK; Semendiaeva ME; Doronin PP
    Ter Arkh; 1973 Apr; 45(4):41-50. PubMed ID: 4723362
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver.
    Di Nicuolo G; D'Alessandro A; Andria B; Scuderi V; Scognamiglio M; Tammaro A; Mancini A; Cozzolino S; Di Florio E; Bracco A; Calise F; Chamuleau RA
    Xenotransplantation; 2010; 17(6):431-9. PubMed ID: 21158944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological aspects of evolutive hepatopathies].
    Danieli G; Montroni M; Corvetta A; Piani M; Polsonetti R
    Minerva Med; 1978 Jun; 69(30):2035-43. PubMed ID: 683565
    [No Abstract]   [Full Text] [Related]  

  • 12. Xenogeneic bioartificial liver support: where are we now?
    Sheil AG
    Transplant Proc; 2002 Sep; 34(6):2493-5. PubMed ID: 12270490
    [No Abstract]   [Full Text] [Related]  

  • 13. Why bioartificial liver support remains the Holy Grail.
    Friedman AL
    ASAIO J; 1998; 44(4):241-3. PubMed ID: 9682947
    [No Abstract]   [Full Text] [Related]  

  • 14. [The bioartificial liver: hopes and realities].
    Samuel D
    Gastroenterol Clin Biol; 2002; 26(8-9):721-3. PubMed ID: 12434075
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of targets of human preformed natural antibodies.
    Citterio F; Maggiano N; Tartaglione R; Foco M; Gattavilla N; Pozzetto U; Marinelli R; Azzaretto M; Castagneto M
    Transplant Proc; 1992 Apr; 24(2):437-8. PubMed ID: 1566378
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subjects and problems in enzyme-bound immunoglobulin study].
    Kanno T
    Rinsho Byori; 1984 Nov; Spec No 60():9-16. PubMed ID: 6085122
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of immunogenic RNA extracted from peritoneal exudate cells and Kupffer cells of the rat.
    Archer SJ; Wust CJ
    Ann N Y Acad Sci; 1973 May; 207():241-50. PubMed ID: 4126321
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of preformed antibody activity to xenoantigens utilizing dithiol-reducing agents.
    Sanchez JA; Fong JC; Watkins JF; Berger CL; Xu-He ; Reemtsma K; Rose EA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):885-6. PubMed ID: 1990713
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.
    Rode A; Nicoll A; Møller HJ; Lim L; Angus PW; Kronborg I; Arachchi N; Gorelik A; Liew D; Kazankov K; Vilstrup H; Grønbæk H
    Gut; 2013 Aug; 62(8):1231-2. PubMed ID: 23442440
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokines and chronic liver disease.
    Fainboim L; Cherñavsky A; Paladino N; Flores AC; Arruvito L
    Cytokine Growth Factor Rev; 2007; 18(1-2):143-57. PubMed ID: 17324606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.